Hansa Biopharma AB (HNSBF)
2.83
0.00 (0.00%)
USD |
OTCM |
Dec 16, 16:00
Hansa Biopharma PE Ratio (Forward)
PE Ratio (Forward) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Forward PE Ratio Definition
The Forward Price to Earnings (PE) Ratio is similar to the price to earnings ratio. The regular P/E ratio is a current stock price over its earnings per share. The forward P/E ratio is a current stock's price over its "predicted" earnings per share. If the forward P/E ratio is higher than the current P/E ratio, it indicates decreased expected earnings.
PE Ratio (Forward) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio (Forward) Benchmarks
| Abliva AB | -- |
| Oncopeptides AB | -- |
| BioInvent International AB | -- |
| BioArctic AB | -- |
| Camurus AB | -- |